These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28164378)

  • 1. Patient with a novel purine-rich element binding protein A mutation.
    Okamoto N; Nakao H; Niihori T; Aoki Y
    Congenit Anom (Kyoto); 2017 Nov; 57(6):201-204. PubMed ID: 28164378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotype of PURA-related neurodevelopmental disorder: a close differential diagnosis of infantile hypotonia with psychomotor retardation and characteristic facies.
    Mishra S; Girisha KM; Shukla A
    Clin Dysmorphol; 2021 Jan; 30(1):1-5. PubMed ID: 33229923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
    Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
    Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.
    Dai W; Sun Y; Fan Y; Gao Y; Zhan Y; Wang L; Xiao B; Qiu W; Gu X; Sun K; Yu Y; Xu N
    Eur J Hum Genet; 2023 Jan; 31(1):112-121. PubMed ID: 36376392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel
    Rodríguez-García ME; Cotrina-Vinagre FJ; Arranz-Canales E; Aragón AM; Hernández-Sánchez L; Rodríguez-Fornés F; Carnicero-Rodríguez P; Morales-Conejo M; Martín-Hernández E; Martínez-Azorín F
    J Genet; 2020; 99():. PubMed ID: 32089526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome.
    Lalani SR; Zhang J; Schaaf CP; Brown CW; Magoulas P; Tsai AC; El-Gharbawy A; Wierenga KJ; Bartholomew D; Fong CT; Barbaro-Dieber T; Kukolich MK; Burrage LC; Austin E; Keller K; Pastore M; Fernandez F; Lotze T; Wilfong A; Purcarin G; Zhu W; Craigen WJ; McGuire M; Jain M; Cooney E; Azamian M; Bainbridge MN; Muzny DM; Boerwinkle E; Person RE; Niu Z; Eng CM; Lupski JR; Gibbs RA; Beaudet AL; Yang Y; Wang MC; Xia F
    Am J Hum Genet; 2014 Nov; 95(5):579-83. PubMed ID: 25439098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the neurodevelopmental phenotype of PURA syndrome.
    Lee BH; Reijnders MRF; Abubakare O; Tuttle E; Lape B; Minks KQ; Stodgell C; Bennetto L; Kwon J; Fong CT; Gripp KW; Marsh ED; Smith WE; Huq AM; Coury SA; Tan WH; Solis O; Mehta RI; Leventer RJ; Baralle D; Hunt D; Paciorkowski AR
    Am J Med Genet A; 2018 Jan; 176(1):56-67. PubMed ID: 29150892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in manifestations of epilepsy and developmental delay in PURA syndrome and 5q31 microdeletions.
    Kofoed AWS; Kristiansen SS; Miranda MJ; Rubboli G; Johannesen KM
    Clin Genet; 2024 Oct; 106(4):386-393. PubMed ID: 38923490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options.
    Mroczek M; Iyadurai S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa.
    Cinquina V; Ciaccio C; Venturini M; Masson R; Ritelli M; Colombi M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1562. PubMed ID: 33275834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.
    Reijnders MRF; Janowski R; Alvi M; Self JE; van Essen TJ; Vreeburg M; Rouhl RPW; Stevens SJC; Stegmann APA; Schieving J; Pfundt R; van Dijk K; Smeets E; Stumpel CTRM; Bok LA; Cobben JM; Engelen M; Mansour S; Whiteford M; Chandler KE; Douzgou S; Cooper NS; Tan EC; Foo R; Lai AHM; Rankin J; Green A; Lönnqvist T; Isohanni P; Williams S; Ruhoy I; Carvalho KS; Dowling JJ; Lev DL; Sterbova K; Lassuthova P; Neupauerová J; Waugh JL; Keros S; Clayton-Smith J; Smithson SF; Brunner HG; van Hoeckel C; Anderson M; Clowes VE; Siu VM; Ddd Study T; Selber P; Leventer RJ; Nellaker C; Niessing D; Hunt D; Baralle D
    J Med Genet; 2018 Feb; 55(2):104-113. PubMed ID: 29097605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing identified a de novo mutation of PURA gene in a patient with familial Xp22.31 microduplication.
    Qiao Y; Bagheri H; Tang F; Badduke C; Martell S; Lewis SME; Robinson W; Connolly MB; Arbour L; Rajcan-Separovic E
    Eur J Med Genet; 2019 Feb; 62(2):103-108. PubMed ID: 29908350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases.
    Brown N; Burgess T; Forbes R; McGillivray G; Kornberg A; Mandelstam S; Stark Z
    Am J Med Genet A; 2013 Oct; 161A(10):2604-8. PubMed ID: 23950017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
    Lezon-Geyda K; Najfeld V; Johnson EM
    Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PURA Syndrome and Myotonia.
    Trau SP; Pizoli CE
    Pediatr Neurol; 2020 Mar; 104():62-63. PubMed ID: 31911028
    [No Abstract]   [Full Text] [Related]  

  • 17. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features.
    Steinfeld H; Cho MT; Retterer K; Person R; Schaefer GB; Danylchuk N; Malik S; Wechsler SB; Wheeler PG; van Gassen KL; Terhal PA; Verhoeven VJ; van Slegtenhorst MA; Monaghan KG; Henderson LB; Chung WK
    Neurogenetics; 2016 Jul; 17(3):159-64. PubMed ID: 27003583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome.
    Hosoki K; Ohta T; Natsume J; Imai S; Okumura A; Matsui T; Harada N; Bacino CA; Scaglia F; Jones JY; Niikawa N; Saitoh S
    Am J Med Genet A; 2012 Aug; 158A(8):1891-6. PubMed ID: 22711443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdeletion and microduplication of 1p36.11p35.3 involving AHDC1 contribute to neurodevelopmental disorder.
    Wang Q; Huang X; Liu Y; Peng Q; Zhang Y; Liu J; Yuan H
    Eur J Med Genet; 2020 Jan; 63(1):103611. PubMed ID: 30615951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.